Abstract

Fragile X Syndrome (FXS), a neurodevelopmental disorder, is the most prevalent single-gene cause of autism spectrum disorder. Autism has been associated with impaired auditory processing, abnormalities in the auditory brainstem response (ABR), and reduced cell number and size in the auditory brainstem nuclei. FXS is characterized by elevated cortical responses to sound stimuli, with some evidence for aberrant ABRs. Here, we assessed ABRs and auditory brainstem anatomy in Fmr1 -/- mice, an animal model of FXS. We found that Fmr1 -/- mice showed elevated response thresholds to both click and tone stimuli. Amplitudes of ABR responses were reduced in Fmr1 -/- mice for early peaks of the ABR. The growth of the peak I response with sound intensity was less steep in mutants that in wild type mice. In contrast, amplitudes and response growth in peaks IV and V did not differ between these groups. We did not observe differences in peak latencies or in interpeak latencies. Cell size was reduced in Fmr1 -/- mice in the ventral cochlear nucleus (VCN) and in the medial nucleus of the trapezoid body (MNTB). We quantified levels of inhibitory and excitatory synaptic inputs in these nuclei using markers for presynaptic proteins. We measured VGAT and VGLUT immunolabeling in VCN, MNTB, and the lateral superior olive (LSO). VGAT expression in MNTB was significantly greater in the Fmr1 -/- mouse than in wild type mice. Together, these observations demonstrate that FXS affects peripheral and central aspects of hearing and alters the balance of excitation and inhibition in the auditory brainstem.

Highlights

  • Fragile X syndrome (FXS) is the most common single-gene inherited form of autism

  • We found that ventral cochlear nucleus (VCN) and medial nucleus of the trapezoid body (MNTB) cell size was decreased in Fmr1-/- mice compared to wild type animals, and MNTB showed increased expression of vesicular GABA transporter protein (VGAT) relative to vesicular glutamate transporter protein (VGLUT) expression within the MNTB

  • KO mice had elevated thresholds compared to controls at each of the five pure tone stimuli tested (Fig. 1C; Table 1), with significance ascertained after Bonferroni correction

Read more

Summary

Introduction

Fragile X syndrome (FXS) is the most common single-gene inherited form of autism. FXS results from an expansion of the CGG repeats in the promoter region of the FMR1 gene, which reduces the amount of fragile X mental retardation protein (FMRP) produced. FMRP acts as a modulator of mRNA translation and has numerous target genes [1, 2]; its loss results in unregulated production of synaptic proteins [3]. Individuals with FXS display cognitive impairments, hyperactivity, seizures, aberrant dendritic spine morphology and several autism-related symptoms [4,5,6,7,8]. FXS subjects display a general enhancement of response to sensory stimuli. When presented with an array of stimuli that spanned several sensory modalities, individuals with FXS

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call